3 mg Bortenat Bortezomib Injection

Listing ID #3183654

his medication is an antineoplastic agent, prescribed for multiple myeloma and mantle cell lymphoma. It works by killing cancer cells. Bortezomib harms cancer cells causing their death.It comes as a solution for injection to be administered by a healthcare provider into the vein. Adult: IV- 1.3 mgm2 as bolus on days 1, 4, 8 and 11 of a 21-day cycle, followed by a 10-day rest period (days 12-21).